Free Trial

Harmony Biosciences (HRMY) Insider Trading & Ownership

Harmony Biosciences logo
$34.28 +0.39 (+1.15%)
(As of 12/20/2024 05:31 PM ET)

Harmony Biosciences (NASDAQ:HRMY) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
30.80%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$1.27 M
Get HRMY Insider Trade Alerts

Want to know when executives and insiders are buying or selling Harmony Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

HRMY Insider Buying and Selling by Quarter

Harmony Biosciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/29/2024Jeffrey DierksinsiderSell21,496$40.47$869,943.12  
9/27/2024Jeffrey DierksinsiderSell200$40.05$8,010.00  
3/15/2024Jeffrey DierksinsiderSell11,979$32.00$383,328.00  
3/8/2024Jeffrey DierksinsiderSell194$32.00$6,208.00  
(Data available from 1/1/2013 forward)

HRMY Insider Trading Activity - Frequently Asked Questions

The list of insiders at Harmony Biosciences includes Andreas Wicki, Jack Nielsen, Jeffrey Dierks, Jeffrey M. Dayno, John C Jacobs. Learn more on insiders at HRMY.

30.80% of Harmony Biosciences stock is owned by insiders. Learn more on HRMY's insider holdings.

The following insider sold HRMY shares in the last 24 months: Jeffrey Dierks ($1,267,489.12).

Insiders have sold a total of 33,869 Harmony Biosciences shares in the last 24 months for a total of $1,267,489.12 sold.

Harmony Biosciences Key Executives

  • Mr. Jeffrey S. Aronin (Age 56)
    Founder & Non-Executive Chairman
    Compensation: $185.67k
  • Dr. Jeffrey M. Dayno M.D. (Age 67)
    President, CEO & Director
    Compensation: $1.26M
  • Mr. Sandip S. Kapadia CPA (Age 54)
    M.B.A., Executive VP, Chief Administrative Officer & CFO
    Compensation: $813.52k
  • Mr. David Bradshaw
    Head of Technical Operations
  • Luis Sanay
    Head of Investor Relations
  • Mr. Christian Ulrich
    General Counsel & Corporate Secretary
  • Ms. Tricia Glover
    Chief Compliance Officer
  • Ms. Audrey Murphy SPHR
    Vice Presidet of Human Resources
  • Ms. Cate McCanless
    Head of Corporate Affairs & Public Policy
  • Ms. Kelli Wright
    Senior Manager of Patient Advocacy & Harmony Biosciences


This page (NASDAQ:HRMY) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners